Burrows Scott L

Chief Financial Officer

Burrows Scott L has filed 9 SEC Form 4 filings (29 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.

On the most recent filing, Burrows Scott L is listed as Chief Financial Officer at Spyre Therapeutics, Inc. Inside the rolling window, Burrows Scott L reported no open-market purchases and 9 open-market sales totaling $6.9M in SYRE. The largest disclosed transaction in the window is a sale of 18,232 SYRE shares on Sep 2, 2026, worth $1.6M.

Companies traded

Other insiders at SYRE

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$6.9M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
SYRESale$655KSep 4SEC ↗
SYRESale$1.6MSep 4SEC ↗
SYRESale$717KAug 6SEC ↗
SYRESale$658KJul 3SEC ↗
SYRESale$1.3MJun 27SEC ↗
SYRESale$533KJun 4SEC ↗
SYRESale$892KMay 2SEC ↗
SYRESale$370KApr 3SEC ↗
SYRESale$102KMar 3SEC ↗
Showing 1–9 of 9
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 2, 2025SYRESale$300K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Burrows Scott L made?

Burrows Scott L has filed 9 SEC Form 4 filings (29 transaction rows) across 1 company since 2025.

Which companies does Burrows Scott L trade?

Burrows Scott L has filed SEC Form 4 disclosures for 1 company, including SYRE.

When was Burrows Scott L's most recent SEC Form 4 filing?

Burrows Scott L's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.

What is Burrows Scott L's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Burrows Scott L is listed as Chief Financial Officer.

What is Burrows Scott L's total buy and sell value in the current window?

Inside the rolling retention window, Burrows Scott L bought $0 and sold $6.9M based on SEC Form 4 filings.

What was Burrows Scott L's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 18,232 SYRE shares on 2026-09-02, worth $1.6M, per SEC Form 4 filings.